361 Results (Page 11 of 15)
Saudi Arabia Markets Research Reports
Saudi Arabia Antibacterial (Antibiotics) Drugs Market Analysis
Saudi Arabia Antibacterial (Antibiotics) Drugs Market is at around $0.86 Bn in 2023 and is projected to reach $1.2 Bn in 2030, exhibiting a CAGR of 5.7% during the forecast period. The market is being driven by rising healthcare expenditures, rapid urbanization, and an increase in the prevalence of infectious diseases. The market is dominated by key players like Hikma Pharmaceuticals, Tabuk Pharmaceuticals, AbbVie, Pfizer, GlaxoSmithKline (GSK), Johnson & Johnson Inc. (J&J), Merck & Co., Sanofi, Novartis, and F. Hoffmann-La Roche Ltd.
Saudi Arabia Dermatological Therapeutics Market Analysis
Saudi Arabia Dermatological Therapeutics Market is at around $0.71 Bn in 2023 and is projected to reach $1.38 Bn in 2030, exhibiting a CAGR of 10.1% during the forecast period. The market is expanding due to trends in cosmetic dermatology, supportive regulatory frameworks, and growing distribution networks. The market is dominated by key players like Jamjoom Pharma Company, Tabuk Pharmaceutical Manufacturing Company, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.
Saudi Arabia Alopecia (Hair Loss) Therapeutics Market Analysis
The Saudi Arabia Alopecia (Hair Loss) Therapeutics Market was valued at US $139 Mn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $278 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of alopecia (hair loss), growing healthcare infrastructure, and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Cipla, Mylan, Theradome, and Pfizer, among others.
Saudi Arabia Allergy Therapeutics Market Analysis
Saudi Arabia allergy therapeutics market was valued at $394 Mn in 2022 and is estimated to reach $725 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The market for allergy therapeutics is expanding as a result of the rising incidence of allergic illnesses and associated medical conditions. Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló, and Stallergenes Greer are few leading companies working in the allergy therapeutics market.
Saudi Arabia Digital Therapeutics Market Analysis
Saudi Arabia Digital Therapeutics Market is at around $0.11 Bn in 2023 and is projected to reach $0.62 Bn in 2030, exhibiting a CAGR of 28.7% during the forecast period. The industry is growing as a result of cultural acceptance, technological advancements, and the rising incidence of chronic diseases. The market is dominated by key players like DoctorNow, Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
Saudi Arabia Alcohol Addiction Therapeutics Market Analysis
The Saudi Arabia Alcohol Addiction Therapeutics Market is valued at around $12 Mn in 2022 and is projected to reach $22 Mn by 2030, exhibiting a CAGR of 7.8% during the forecast period. The Therapeutics Sector is facing an expanding market opportunity due to the changing demographic landscape, with younger people who are more exposed to global trends and have more disposable income, as well as increased awareness of alcoholism as a treatable disorder and limited treatment options in Saudi Arabia. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Saudi Arabia are GlaxoSmithKline, Lundbeck, TEVA, Roche, Eli Lilly, AstraZeneca, Cipla, Naseej, Taamer, Sun Pharmaceuticals, etc among others
Saudi Arabia Cardiovascular Drugs Market Analysis
Saudi Arabia Cardiovascular Drug Market is at around $2.4 Bn in 2022 and is projected to reach $3.6 Bn in 2030, exhibiting a CAGR of 5.3% during the forecast period. The market is propelling due to factors such as government initiatives & early detection of the disease, rising levels of disposable income in the country, and adoption of unhealthy lifestyle patterns. The market is dominated by key players like Tabuk Pharmaceuticals, Jamjoom Pharma, Pfizer Inc., Novartis, Sanofi, Merck & Co., Astra Zeneca, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Gilead Sciences, and Bayer AG.
Saudi Arabia Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Saudi Arabia Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $56 Mn in 2022, and is predicted to grow at (CAGR) of 9.3% from 2023 to 2030, to US $114 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, international collaborations by KSA, increased government funding initiatives, and other factors. The industry is primarily dominated by players such as SPIMACO, Julphar, Jamjoom, Novartis, Sanofi, Pfizer Inc, among other players
Saudi Arabia Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Saudi Arabia Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $19 Mn in 2022, and is predicted to grow at a CAGR of 7.3% from 2023 to 2030, to US $33 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, increased awareness, and other factors. The industry is primarily dominated by players such as Otsuka, Sanofi, Pfizer, and Janssen Pharmaceutical, among others
Saudi Arabia Age-Related Macular Degeneration Therapeutics Market Analysis
The Saudi Arabia Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $184 Mn in 2022, and is predicted to grow at a CAGR of 10.4% from 2023 to 2030, to US $405 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, technological advancements, and other factors. The industry is primarily dominated by players such as Regeneron Pharmaceuticals, Novartis, Bayer, Roche, and Genetech, among others
Saudi Arabia Addiction Therapeutics Market Analysis
Saudi Arabia addiction therapeutics market was valued at $172 Mn in 2022 and is estimated to reach $327 Mn in 2030, exhibiting a CAGR of 8.4% during the forecast period. The market is growing as the government is committed to addressing substance abuse problems by increasing mental health awareness and accessibility and improving access to addiction treatment facilities. The key players in addiction therapeutics market are Eradah (Al Amal) Mental Health Complex, Taif Mental Health Hospital, KAAUH developmental Hospital, Pfizer, Novartis, GSK, Johns Hopkins Aramco Healthcare Dhahran, Dr. Sulaiman Al-Habib Medical Group, AbbVie and Saudi German Hospitals Group
Saudi Arabia Adult Malignant Glioma Therapeutics Market Analysis
The Saudi Arabia Adult Glioma Therapeutics Market is valued at around $37 Mn in 2022 and is projected to reach $83 Mn by 2030, exhibiting a CAGR of 10.4% during the forecast period. An upsurge in the market is being driven by factors such as increased general awareness, tailored medication preferences, increased government backing, and demographic and urbanisation shifts. Key players in the Saudi Arabia Adult Malignant Glioma Therapeutics Market include companies like Mylan N.V., Teva Pharmaceuticals, Sanofi, Pfizer, GlaxoSmithKline plc., Novartis, Bayer, Merck & Co, etc.
Saudi Arabia Physiotherapy Market Analysis
This report presents a strategic analysis of the Saudi Arabia Physiotherapy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Saudi Arabian Physiotherapy Market, offering unmatched value, accuracy, and expert insights.
Saudi Arabia Palliative Care Market Analysis
Saudi Arabia's Palliative care market is projected to grow from $222.36 Mn in 2022 to $459.59 Mn by 2030, registering a CAGR of 9.5% during the forecast period of 2022-30. The main factors driving the growth would be an increasing aging population, a rise in the prevalence of chronic diseases, and government support. The market is segmented by service type and by the end user. Some of the major players include King Fahad Medical City, King Faisal Specialist Hospital, and Research Center, Salam Medical, and others.
Saudi Arabia Oncology Drugs Market Analysis
This report presents a strategic analysis of the Saudi Arabia Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Saudi Arabian Oncology Drugs Market, offering unmatched value, accuracy, and expert insights.
Saudi Arabia Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Saudi Arabia Liver Cancer Therapeutics market will reach a value of $201.7 Mn from $49.8 Mn in 2022, growing at a CAGR of 19.1 % during 2022-30. Liver Cancer Therapeutics in Saudi Arabia is dominated by a few domestic pharmaceutical companies such as Jamjoom Pharma, Tabuk Pharmaceuticals, and SPIMACO. The Liver Cancer Therapeutics market in Saudi Arabia is segmented into different types of cancer and different therapy types. Some of the major factors affecting the Saudi Arabia Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Saudi Arabia Healthcare Claims Management Market Analysis
Saudi Arabia's healthcare claims management market is projected to grow from $453.9 Mn in 2022 to $2688.19 Mn by 2030, registering a CAGR of 24.9% during the forecast period of 2022-30. The main factors driving the growth would be the increasing prevalence of chronic disease, government initiatives, adoption of digital solutions, and growth in healthcare spending. The market is segmented by component, type, delivery mode, and end-user. Some of the major players include Tawuniya, Total Care Saudi, MedNet, and Cognizant.
Saudi Arabia ENT Devices Market Analysis
Saudi Arabia's ENT Devices Market is projected to grow from $390 Mn in 2022 to $690 Mn by 2030, registering a CAGR of 7.3% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Saudi Arabia ENT devices market include Al Danah Medical Company, Al Faisaliah Medical Systems, and Al Zahrawi Medical Supplies.
Saudi Arabia ECG Equipments Market Analysis
Saudi Arabia's ECG Equipment Market is expected to witness growth from $151 Mn in 2022 to $297 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-30. The elderly population in Saudi Arabia is expanding and is more likely to develop heart disease and other chronic ailments, the growing geriatric population is predicted to raise demand for ECG equipment in the nation. The market is segmented by product type and by end user. Some key players in this market include Al Madar Medical, Aljeel Medical, Alhammad Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Saudi Arabia Diabetes Devices Market Analysis
Saudi Arabia's Diabetes Devices Market is expected to witness growth from $386 Mn in 2022 to $753 Mn in 2030 with a CAGR of 8.70% for the forecasted year 2022-30. One of the greatest rates of diabetes is found in Saudi Arabia. As more individuals need access to blood glucose monitors, insulin pumps, and other diabetes management tools, this expands the market for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Aljeel Medical, Alhammad Medical, Medyssey, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche, and Dexcom.
Saudi Arabia Contraceptive Devices Market Analysis
Saudi Arabia's Contraceptive Devices Market is expected to witness growth from $219 Mn in 2022 to $453 Mn in 2030 with a CAGR of 9.50% for the forecasted year 2022-30. Saudi Arabia is becoming more and more conscious of the value of family planning, which has increased the demand for contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Tabuk Pharmaceuticals, SITCO Pharma, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Saudi Arabia Acne Therapeutics Market Analysis
This report presents a strategic analysis of the Saudi Arabia Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Saudi Arabian Acne Therapeutics Market, offering unmatched value, accuracy, and expert insights.
Saudi Arabia Vaccines Market Analysis
This report presents a strategic analysis of the Saudi Arabia Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Saudi Arabia vaccine market, offering unmatched value, accuracy, and expert insights.
Saudi Arabia Sleep Disorders Market Analysis
This report presents a strategic analysis of the Saudi Arabia Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Saudi Arabia Sleep Disorders Market, offering unmatched value, accuracy, and expert insights.
Saudi Arabia Coronary Stents Market Analysis
Saudi Arabia's Coronary Stents Market is expected to witness growth from $192 Mn in 2022 to $312 Mn in 2030 with a CAGR of 6.25% for the forecasted year 2022-30. In Saudi Arabia, people are becoming more aware of cardiovascular health and are acting more proactively to seek treatment for heart disease. This is increasing demand for coronary stents as patients and medical professionals look for efficient CAD treatments. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Al Madar Medical, Aljeel Medical, Alhammad Medical, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.